You are here

P&T® Journal contents for May 2002


Drug Shortages (4-Part Series)
When it comes to influenza vaccines, the timing of the distribution can create both shortages and surpluses.
Keiji Fukuda, MD, MPH, Dennis O’Mara, and James A. Singleton, MS
Guest Commentary
The withdrawl of Baycol illustrates the need for better monitoring of patients and adverse reactions.
Ivan Goldsmith, MD, Ross W. Newman, and William Dachman, MD
Continuing Education
This article discusses both the conventional treatment and investigational agents for this disease.
Dena M. Behm Dillon, PharmD and Linda M. Schrand, PharmD


Editor-in-Chief David B. Nash would like all health systems to be more like “Learning Organizations.”
David Nash, MD, MBA
Prescription Washington
Stephen Barlas
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Drug Forecast
A new antifungal agent to treat a broad spectrum of mycoses.
Nicholas S. Vanni, PharmD and Michael T. Inzerillo, RPh
Medication Errors
Matthew Grissinger, RPh, cautions all health care providers about the dangers of enteral nutrition containers.